Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-04-06
1988-07-26
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548444, A61K 3140
Patent
active
047600853
ABSTRACT:
The present invention is concerned with the topical use of D,L- and D-carazolol and of the pharmacologically acceptable salts in the therapy of glaucoma. The present invention is also concerned with eye drops containing these active materials.
REFERENCES:
patent: 4503067 (1985-03-01), Wiedemann
The Merck Index, 9th ed. (1976), No. 9170.
The Merck Index, 10th ed., (1983), No. 1753.
AMA Drug Evaluations, 5th ed., (4-1983), p. 457.
Manalan et al., Circ. Res. 49: 326-336 (1981).
Boehringer Mannheim GmbH
Ramsuer Robert W.
LandOfFree
Use of D,L-and D-carazolol as anti-glaucoma agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of D,L-and D-carazolol as anti-glaucoma agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of D,L-and D-carazolol as anti-glaucoma agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-258204